Incyte Taps Wide-Open Vitiligo Market With Positive Ruxolitinib Results

Phase III Data Could Lead To First Approval

 
• By Alaric DeArment
Vitiligo on the hands. Shutterstock 1621981522
Incyte reported positive Phase III topline results for topical ruxolitinib in vitiligo • Source: Shutterstock

More from Dermatological

More from Therapeutic Category